Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial.
Kuzumi A, Oba K, Ebata S, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Kage H, Sato S, Yoshizaki A. Kuzumi A, et al. Among authors: yoshizaki ogawa a. Rheumatology (Oxford). 2024 Dec 24:keae716. doi: 10.1093/rheumatology/keae716. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39718799
The Number of Nail Fold Capillaries and Nail Fold Bleedings Reflects the Clinical Manifestations of Systemic Sclerosis.
Norimatsu Y, Fukasawa T, Kabeya Y, Toyama S, Matsuda KM, Kuzumi A, Yoshizaki-Ogawa A, Ichimura H, Yonezawa S, Nakano H, Sato S, Yoshizaki A. Norimatsu Y, et al. Among authors: yoshizaki ogawa a. J Invest Dermatol. 2024 Sep 16:S0022-202X(24)02092-X. doi: 10.1016/j.jid.2024.08.020. Online ahead of print. J Invest Dermatol. 2024. PMID: 39293713 No abstract available.
Diversity and Epitope Spreading of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement.
Kotani H, Matsuda KM, Yamaguchi K, Ono C, Kogo E, Ogawa K, Kobayashi Y, Hisamoto T, Kawanabe R, Kuzumi A, Fukasawa T, Yoshizaki-Ogawa A, Goshima N, Sato S, Yoshizaki A. Kotani H, et al. Among authors: yoshizaki ogawa a. Arthritis Rheumatol. 2025 Jan;77(1):67-79. doi: 10.1002/art.42975. Epub 2024 Sep 29. Arthritis Rheumatol. 2025. PMID: 39219033 Free PMC article.
Single cell analysis in systemic sclerosis - A systematic review.
Fukasawa T, Yoshizaki-Ogawa A, Enomoto A, Yamashita T, Miyagawa K, Sato S, Yoshizaki A. Fukasawa T, et al. Among authors: yoshizaki ogawa a. Immunol Med. 2024 Sep;47(3):118-129. doi: 10.1080/25785826.2024.2360690. Epub 2024 May 31. Immunol Med. 2024. PMID: 38818750 Free article. Review.
Detection of late responders from nonresponders to apremilast by simply measuring pruritus at week 4: Results from a prospective cohort observational study.
Fukasawa T, Yoshizaki-Ogawa A, Enomoto A, Yamashita T, Miyagawa K, Sato S, Yoshizaki A. Fukasawa T, et al. Among authors: yoshizaki ogawa a. J Am Acad Dermatol. 2024 Sep;91(3):547-549. doi: 10.1016/j.jaad.2024.05.015. Epub 2024 May 14. J Am Acad Dermatol. 2024. PMID: 38754631 Free article. No abstract available.
48 results